Logo image of TGEN

TECOGEN INC/WALTHAM MA (TGEN) Stock Fundamental Analysis

USA - NYSEARCA:TGEN - US87876P2011 - Common Stock

8.46 USD
+0.04 (+0.48%)
Last: 10/23/2025, 6:57:47 PM
8.8 USD
+0.34 (+4.02%)
After Hours: 10/23/2025, 6:57:47 PM
Fundamental Rating

3

Overall TGEN gets a fundamental rating of 3 out of 10. We evaluated TGEN against 41 industry peers in the Building Products industry. The financial health of TGEN is average, but there are quite some concerns on its profitability. TGEN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TGEN had negative earnings in the past year.
In the past year TGEN had a positive cash flow from operations.
In the past 5 years TGEN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: TGEN reported negative operating cash flow in multiple years.
TGEN Yearly Net Income VS EBIT VS OCF VS FCFTGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

With a Return On Assets value of -15.31%, TGEN is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -46.53%, TGEN is doing worse than 87.80% of the companies in the same industry.
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROIC N/A
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
TGEN Yearly ROA, ROE, ROICTGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

TGEN has a Gross Margin of 43.64%. This is amongst the best in the industry. TGEN outperforms 82.93% of its industry peers.
TGEN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TGEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
TGEN Yearly Profit, Operating, Gross MarginsTGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
TGEN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TGEN has been increased compared to 5 years ago.
TGEN has a worse debt/assets ratio than last year.
TGEN Yearly Shares OutstandingTGEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
TGEN Yearly Total Debt VS Total AssetsTGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

TGEN has an Altman-Z score of 5.52. This indicates that TGEN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of TGEN (5.52) is better than 68.29% of its industry peers.
The Debt to FCF ratio of TGEN is 0.63, which is an excellent value as it means it would take TGEN, only 0.63 years of fcf income to pay off all of its debts.
TGEN has a better Debt to FCF ratio (0.63) than 87.80% of its industry peers.
TGEN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
TGEN has a better Debt to Equity ratio (0.18) than 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Altman-Z 5.52
ROIC/WACCN/A
WACC9.74%
TGEN Yearly LT Debt VS Equity VS FCFTGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

TGEN has a Current Ratio of 1.32. This is a normal value and indicates that TGEN is financially healthy and should not expect problems in meeting its short term obligations.
TGEN has a worse Current ratio (1.32) than 75.61% of its industry peers.
A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
TGEN's Quick ratio of 0.74 is on the low side compared to the rest of the industry. TGEN is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.74
TGEN Yearly Current Assets VS Current LiabilitesTGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

TGEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.48%.
TGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.46%.
The Revenue has been decreasing by -5.52% on average over the past years.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%54.33%

3.2 Future

The Earnings Per Share is expected to grow by 38.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, TGEN will show a very strong growth in Revenue. The Revenue will grow by 22.20% on average per year.
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TGEN Yearly Revenue VS EstimatesTGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
TGEN Yearly EPS VS EstimatesTGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TGEN Price Earnings VS Forward Price EarningsTGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TGEN is valued a bit more expensive than 70.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 81.25
EV/EBITDA N/A
TGEN Per share dataTGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

A cheap valuation may be justified as TGEN's earnings are expected to decrease with -20.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TGEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TECOGEN INC/WALTHAM MA

NYSEARCA:TGEN (10/23/2025, 6:57:47 PM)

After market: 8.8 +0.34 (+4.02%)

8.46

+0.04 (+0.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-06 2025-11-06
Inst Owners15.06%
Inst Owner Change1.74%
Ins Owners23.08%
Ins Owner Change5.96%
Market Cap251.18M
Revenue(TTM)25.00M
Net Income(TTM)-4760300
Analysts82.86
Price Target15.3 (80.85%)
Short Float %6.65%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-189.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-49.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.1
P/FCF 81.25
P/OCF 61.86
P/B 24.55
P/tB 46.77
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY1.23%
OCF(TTM)0.14
OCFY1.62%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.64%
FCFM 13.67%
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 175.01%
Cap/Sales 4.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.74
Altman-Z 5.52
F-Score4
WACC9.74%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%54.33%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.59%
EBIT Next 3Y70.17%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A